Basel Medical Group LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Basel Medical Group Ltd has filed Amendment No. 4 to its Form F-1 registration statement for an initial public offering of 2,205,000 ordinary shares and a resale offering of up to 2,000,000 ordinary shares by selling shareholders.
NASDAQ
Basel Medical Group Ltd has filed an amendment to its F-1 registration statement, detailing its initial public offering of 2,500,000 ordinary shares and a potential resale of 2,000,000 shares by existing shareholders.
NASDAQ
Basel Medical Group Ltd. has filed an amendment to its Form F-1 registration statement, detailing its initial public offering of 2,500,000 ordinary shares and a resale offering of up to 2,000,000 ordinary shares by existing shareholders.
NASDAQ
Basel Medical Group Ltd, a Singapore-based orthopedic and neurosurgery services provider, is seeking to raise capital through an initial public offering of 2,500,000 ordinary shares on the Nasdaq Capital Market.
NASDAQ
Basel Medical Group Ltd, a BVI business company, has filed a registration statement for an initial public offering (IPO) on the Nasdaq Capital Market.